Nanobiotix (NBTX) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $51.1 million.

  • Nanobiotix's Liabilities and Shareholders Equity fell 4521.9% to $51.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $317.5 million, marking a year-over-year increase of 607.93%. This contributed to the annual value of $73.0 million for FY2024, which is 2815.89% down from last year.
  • According to the latest figures from Q2 2025, Nanobiotix's Liabilities and Shareholders Equity is $51.1 million, which was down 4521.9% from $72.0 million recorded in Q4 2024.
  • Nanobiotix's Liabilities and Shareholders Equity's 5-year high stood at $149.2 million during Q2 2021, with a 5-year trough of $44.0 million in Q2 2023.
  • Over the past 5 years, Nanobiotix's median Liabilities and Shareholders Equity value was $79.0 million (recorded in 2022), while the average stood at $82.2 million.
  • Per our database at Business Quant, Nanobiotix's Liabilities and Shareholders Equity crashed by 4885.51% in 2023 and then skyrocketed by 11214.61% in 2024.
  • Over the past 5 years, Nanobiotix's Liabilities and Shareholders Equity (Quarter) stood at $149.2 million in 2021, then crashed by 59.14% to $61.0 million in 2022, then surged by 65.68% to $101.0 million in 2023, then decreased by 28.69% to $72.0 million in 2024, then decreased by 29.02% to $51.1 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $51.1 million for Q2 2025, versus $72.0 million for Q4 2024 and $93.3 million for Q2 2024.